Squarepoint’s Biohaven BHVN Stock Holding History

Squarepoint’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,600	Closed	-$396K	–	4597
2024 Q4	$396K	Buy	+10,600	New	+$495K	﹤0.01%	3934

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint's BHVN Position: Q2 2026 in Review

Squarepoint reduced its Biohaven (BHVN) stake by 39% in Q2 2026, selling an estimated $738K and leaving 109,161 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2499.

Squarepoint first reported a position in BHVN in Q1 2023 and has held it in 7 quarters since. The position peaked at $3.62M in Q3 2025. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Squarepoint held 109,161 shares of Biohaven worth $1.62M as of Q2 2026.
Squarepoint sold 68,517 Biohaven shares in Q2 2026, an estimated $738K.
Biohaven made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2499 holding.
Squarepoint first reported a position in Biohaven in Q1 2023 and has held it in 7 quarters since.
Squarepoint's Biohaven position peaked at $3.62M in Q3 2025.
296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.